Companion Diagnostics Marketgrowth, Future Prospects and Competitive Analysis, 2016-2023

Global Companion Diagnostics Market to Reach Worth USD 14,453.3 Mn by 2023

Global Companion Diagnostics Market to Reach Worth USD 14,453.3 Mn by 2023: Increased Popularity of Personalized Medicines is one of the Major Drivers in this Market

According to the latest report published by Credence Research, Inc. “Companion Diagnostics Market – (Technology Type – Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization Test, Gene Sequencing and Others; Indication Type – Oncology, Cardiovascular Diseases, Infectious Diseases and Autoimmune Diseases): Growth, Future Prospects and Competitive Analysis, 2016-2023,” the market was valued at USD 3,717.2 Mn in 2015, and is expected to reach USD 14,453.3 Mn by 2023, expanding at a CAGR of 18.5% from 2016 to 2023.

Browse the full report Companion Diagnostics: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/companion-diagnostics-market

Market Insights

Companion diagnostic tests are used to identify suitable patients for administering specific drugs and monitoring the prognosis of drug effects on the disease. This concept of combining a drug with a diagnostic test is known as predictive medicine or personalized medicine. A companion diagnostic test has the ability to predict the risks of the disease and monitor its therapeutic response. On the basis of technology the companion diagnostics market has been segmented into polymerase chain reaction, immunohistochemistry, In-situ hybridization test, gene sequencing and others. The others segment includes tests such as monoclonal antibodies test and cellular immune testing. The polymerase chain reaction technique is the largest segment in the global companion diagnostics market.

On the basis of indication the global companion diagnostics market has been segmented as oncology, cardiovascular diseases, virology and autoimmune diseases. The...